Copyright
©The Author(s) 2021.
World J Hepatol. May 27, 2021; 13(5): 584-594
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.584
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.584
Univariate HR (95%CI) | P value | Multivariate HR (95%CI) | P value | |
Sex (male) | 0.82 (0.20-3.31) | 0.779 | ||
Age | 0.99 (0.96-1.03) | 0.694 | ||
Pathology (HAS/UDS) | 0.50 (0.12-2.07) | 0.339 | 0.63 (0.11-3.55) | 0.602 |
Largest tumor size | 1.13 (1.00-1.27) | 0.049 | 1.12 (0.97-1.28) | 0.115 |
Tumor number | 1.28 (0.79-2.07) | 0.311 | ||
AFP | 1.02 (0.77-1.33) | 0.917 | ||
CA 19-9 | 1.00 (1.00-1.00) | 0.527 | ||
Adjuvant therapy | 0.24 (0.04-1.47) | 0.121 | 0.25 (0.04-1.71) | 0.157 |
- Citation: Kim SJ, Rhu J, Kim JM, Choi GS, Joh JW. Surgical treatment outcomes of primary hepatic sarcomas: A single-center experience. World J Hepatol 2021; 13(5): 584-594
- URL: https://www.wjgnet.com/1948-5182/full/v13/i5/584.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i5.584